Publication | Closed Access

Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study

Interim AnalysisSurgical OncologyOncologyGastrointestinal OncologyGastroenterologyPathologyAdvanced GastricCancer TreatmentMedicineRadiation OncologyPhase 3